Literature DB >> 26705338

Enlightening light chain deposition disease.

Giampaolo Merlini1, Giovanni Palladini1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26705338     DOI： 10.1182/blood-2015-10-672626

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function.

Authors:  Paolo Milani; Marco Basset; Paola Curci; Andrea Foli; Rita Rizzi; Mario Nuvolone; Raffaella Guido; Loreto Gesualdo; Giorgina Specchia; Giampaolo Merlini; Giovanni Palladini
Journal:  Blood Adv       Date:  2020-04-14

2.  Light-Chain Deposition Disease with Prominent Hepatic Involvement.

Authors:  Ana Cristino; Carmen Pais; Renata Silva; Paulo Carrola
Journal:  Eur J Case Rep Intern Med       Date:  2017-04-27

3.  Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma.

Authors:  Aneta Schieferdecker; Sebastian Hörber; Monika Ums; Britta Besemer; Carsten Bokemeyer; Andreas Peter; Katja Weisel
Journal:  Blood Cancer J       Date:  2020-01-09       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.